IQVIA Releases 2025 Sustainability Report: A Commitment to People, Public Health, and Planet

On February 27, 2026, IQVIA Holdings Inc. (NYSE: IQV), a leader in the provision of clinical research services and healthcare intelligence, unveiled its 2025 Sustainability Report. This report showcases the company's dedication to enhancing global health through a holistic approach that encompasses its People, Public Health, and Planet initiatives. The report outlines significant advancements made in various areas, reflecting IQVIA’s ongoing commitment to innovation and sustainability.

Central to IQVIA's mission are its approximately 93,000 employees worldwide. In 2025, the company made substantial investments in employee development, focusing on enhancing skills in artificial intelligence (AI) and data analytics. Notably, IQVIA facilitated over 230,000 employee engagements with AI learning resources and saw more than 2,000 employees participating in leadership development programs. This strategic emphasis on employee engagement has led IQVIA to exceed Fortune 500 benchmarks in key metrics, indicating a strong alignment with its workforce's aspirations and needs.

IQVIA's commitment to innovation is further highlighted by its advancements in AI technologies. The company expanded its AI strategy through key partnerships aimed at enhancing ecosystem interoperability and the launch of new AI-enabled solutions. With a focus on responsible AI usage, IQVIA operates under the guidance of its AI Governance Council, emphasizing privacy, regulatory compliance, and patient safety through its proprietary IQVIA Healthcare-grade AI® capabilities.

The 2025 report underscores IQVIA's efforts to ensure that patients remain at the heart of its research initiatives. In a significant move, IQVIA expanded access to clinical trials by activating sites in Brazil and Argentina for a global acute coronary syndrome trial. This initiative successfully enrolled 5,700 participants, contributing towards a global target of 47,000 participants and ensuring representation from underserved populations in large-scale cardiovascular research. Additionally, IQVIA expanded its network of Prime Sites to 56 high-performing clinical trial centers, furthering its reach in Brazil, Italy, and Japan.

IQVIA leveraged its extensive global presence and scientific expertise to support public health initiatives aimed at tackling complex health challenges. In 2025, the company collaborated with governments, global health organizations, and industry partners to respond to disease outbreaks, advance digital health strategies, and strengthen healthcare systems worldwide. This collaborative approach positions IQVIA as a key player in enhancing global health outcomes.

Addressing environmental impact, IQVIA has undertaken significant measures to reduce its ecological footprint. The report highlights the company’s commitment to the My Green Lab® program, with all global laboratory facilities achieving certification. Innovations such as redesigning clinical trial test kits to utilize at least 98% recycled materials and reducing packaging emissions in cold chain logistics by 70% demonstrate IQVIA’s commitment to sustainable research practices. Furthermore, the company has expanded its ISO 14001 and 45001 certifications across its laboratories, reinforcing its dedication to environmental standards.

IQVIA's efforts in sustainability and innovation have not gone unnoticed. The company received multiple accolades in 2025, including being named to the 2026 *Fortune*® World’s Most Admired Companies™ list for the ninth consecutive year and securing the top position in its category for the fifth year running. Additionally, IQVIA received an "outstanding" score in TIME’s inaugural ranking of the World’s Top HealthTech companies and won the award for best mobile app for patient engagement from the MedTech Breakthrough Awards.

The release of IQVIA's 2025 Sustainability Report reinforces the company's unwavering commitment to enhancing global health through sustainable practices and innovations. By investing in its workforce, advancing AI technology, broadening access to healthcare, and minimizing its environmental impact, IQVIA is not only accelerating innovation but also creating a healthier world for future generations. The report serves as a testament to IQVIA’s strategic vision and its role as a leader in the life sciences and healthcare sectors.